Aro Biotherapeutics reels in $3.5M

The funds will help the Philadelphia biotechnology company, founded by two businesswomen after leaving Johnson & Johnson, advance its research platform.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.